Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 859

1.

CD30-positive atypical lymphoid cells in common non-neoplastic cutaneous infiltrates rich in neutrophils and eosinophils.

Cepeda LT, Pieretti M, Chapman SF, Horenstein MG.

Am J Surg Pathol. 2003 Jul;27(7):912-8.

PMID:
12826883
2.

Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.

Kong YY, Dai B, Kong JC, Lu HF, Shi DR.

Histopathology. 2009 Aug;55(2):189-96. doi: 10.1111/j.1365-2559.2009.03359.x.

PMID:
19694826
3.

Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin.

Werner B, Massone C, Kerl H, Cerroni L.

J Cutan Pathol. 2008 Dec;35(12):1100-7. doi: 10.1111/j.1600-0560.2007.00979.x. Epub 2008 Jun 18.

PMID:
18616762
4.

[Cutaneous neutrophils infiltrates. Case 7. Lymphomatoid papulosis].

Vergier B.

Ann Pathol. 2011 Jun;31(3):198-202. doi: 10.1016/j.annpat.2011.05.004. Epub 2011 Jun 11. French. No abstract available.

PMID:
21737002
5.
6.

[Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis].

Slotosch CM, Hörster S, Hertl M, Schultz E.

Hautarzt. 2010 Jun;61(6):511-3. doi: 10.1007/s00105-009-1786-1. German.

PMID:
19536511
7.

Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions.

Su LD, Duncan LM.

J Cutan Pathol. 2000 May;27(5):249-54.

PMID:
10847550
9.

Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.

Yamaguchi T, Ohshima K, Karube K, Kawano R, Nakayama J, Suzumiya J, Kikuchi M.

Br J Dermatol. 2006 May;154(5):904-9.

PMID:
16634894
10.

Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE.

Brady SP, Magro CM, Diaz-Cano SJ, Wolfe HJ.

Hum Pathol. 1999 Feb;30(2):130-6.

PMID:
10029439
11.

Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders.

Greisser J, Palmedo G, Sander C, Kutzner H, Kazakov DV, Roos M, Burg G, Kempf W.

J Cutan Pathol. 2006 Nov;33(11):711-5.

PMID:
17083688
12.

Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.

Beylot-Barry M, Lamant L, Vergier B, de Muret A, Fraitag S, Delord B, Dubus P, Vaillant L, Delaunay M, MacGrogan G, Beylot C, de Mascarel A, Delsol G, Merlio JP.

Am J Pathol. 1996 Aug;149(2):483-92.

13.

Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin.

Steinhoff M, Hummel M, Anagnostopoulos I, Kaudewitz P, Seitz V, Assaf C, Sander C, Stein H.

Blood. 2002 Jul 15;100(2):578-84.

14.

Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature.

Burg G, Kempf W, Kazakov DV, Dummer R, Frosch PJ, Lange-Ionescu S, Nishikawa T, Kadin ME.

Br J Dermatol. 2003 Mar;148(3):580-6. Review.

PMID:
12653754
15.
17.

Molecular evidence for a clonal relationship between lymphomatoid papulosis and Ki-1 positive large cell anaplastic lymphoma.

Volkenandt M, Bertino JR, Shenoy BV, Koch OM, Kadin ME.

J Dermatol Sci. 1993 Oct;6(2):121-6.

PMID:
8274457
18.

MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Kempf W, Kutzner H, Cozzio A, Sander CA, Pfaltz MC, Müller B, Pfaltz M.

Br J Dermatol. 2008 Jun;158(6):1280-7. doi: 10.1111/j.1365-2133.2008.08566.x. Epub 2008 Apr 10.

PMID:
18410414
19.
20.

Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.

Kazakov DV, Kutzner H, Palmedo G, Boudova L, Michaelis S, Michal M, Vanecek T, Magro CM, Mukensnabl P, Dummer R, Burg G, Kempf W.

Am J Dermatopathol. 2006 Oct;28(5):399-409.

PMID:
17012914

Supplemental Content

Support Center